As we launch into Women in Medicine Month, we recognize the countless contributions of the women who make up 67% of the healthcare workforce across the world¹. You have the gratitude of the whole RefluxStop® team, this month and every month. Learn more about Women in Medicine Month and how you can show your support with resources from American Medical Association: https://lnkd.in/g92P-NfB. #WIMMonth 1. Agyeman-Manu K, Ghebreyesus TA, Maait M, Rafila A, Tom L, Lima NT, Wangmo D. Prioritising the health and care workforce shortage: protect, invest, together. Lancet Glob Health. 2023 Aug;11(8):e1162-e1164. doi: 10.1016/S2214-109X(23)00224-3. Epub 2023 May 17. PMID: 37209702; PMCID: PMC10191605.
RefluxStop™
Herstellung medizinischer Geräte
RefluxStop™ restores the natural function of the esophageal sphincter without encircling the food passageway.
Info
RefluxStop™ treats acid reflux without affecting the food passageway, a novel method that will possibly create a paradigm shift in acid reflux treatment. This ingenious device is a non-active implant and is placed on the upper part of the stomach through laparoscopic (key hole) surgery. CE mark approval was granted August 8, 2018, on the strength of a multi-center clinical investigation in which the safety and effectiveness of the device in patients was demonstrated. Acid reflux is the second largest treatment field in the world, with 400 million daily sufferers1. RefluxStop™ not only treats the symptoms of acid reflux but also eliminates the regurgitation of stomach fluid – unlike drug therapy. The clinical investigation supports that complication rates are reduced with RefluxStop™ compared to current surgical treatments. RefluxStop procedures are currently being performed in the following countries: UK Germany Austria Switzerland Spain Italy
- Website
-
https://www.implantica.com/im-refluxstop/
Externer Link zu RefluxStop™
- Branche
- Herstellung medizinischer Geräte
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Zug
- Spezialgebiete
- Gastroenterology, Acid Reflux, GERD, GORD und Reflux Disease
Updates
-
The American Foregut Society Annual Meeting is around the corner, September 25-29, and if you are still on the fence about going, listen to what Dr. Caitlin Houghton from Keck Medicine of USC has to say! Before AFS, read all about the RefluxStop® 4-year follow up data just published in Surgical Endoscopy: https://lnkd.in/gxvJR_-d
-
RefluxStop™ 4-year follow-up data was just published in the prestigious journal Surgical Endoscopy. See the study: https://lnkd.in/gxvJR_-d The excellent 1-year results continue to be seen 4 years after the RefluxStop™ procedure. * No patient used daily PPIs for reflux symptoms. * 90% improvement in quality-of-life scores. * GERD symptoms are still resolved 4 years post-surgery.
-
4 Year data on the RefluxStop™ Procedure is now available! Read all about it in the journal, Surgical Endoscopy: https://lnkd.in/gxvJR_-d This study followed patients for 4 years and found: * No patient used daily PPIs for reflux symptoms * Nearly complete resolution of GERD symptoms * 90% improvement in quality of life corresponding to substantial patient satisfaction
-
We were thrilled to see RefluxStop™ in this story in Medical Device Network of the first RefluxStop™ procedure completed with robotic surgery in the UK, at University Hospital Southampton NHS FT: https://lnkd.in/g_xksd_t
-
-
4-Year RefluxStop™ results were recently published in the journal Surgical Endoscopy and showed that: * None of the patients needed esophageal dilation. * No readmissions. * No reoperations. In conclusion, the study found there was minimal additional healthcare utilization during this 4-year follow-up period. See the study: https://lnkd.in/gxvJR_-d
-
RefluxStop™ hat dies direkt geteilt
RefluxStop™ 4-year follow-up data was just published in the prestigious journal Surgical Endoscopy. See the study: https://lnkd.in/gxvJR_-d The excellent 1-year results continue to be seen 4 years after the RefluxStop™ procedure. * No patient used daily PPIs for reflux symptoms. * 90% improvement in quality-of-life scores. * GERD symptoms are still resolved 4 years post-surgery.
RefluxStop™ 4-Year Data
-
RefluxStop™ hat dies direkt geteilt
Wow! So exciting to see 4-year Results published in the journal, Surgical Endoscopy, confirm that 4-year outcomes mirror the excellent 1- and 3-year outcomes already reported after the RefluxStop™ procedure. This validates long-term stability and supports the safety and efficacy of the RefluxStop™ device in treating gastroesophageal reflux disease (GERD) over a 4-year timeframe. Surgical Endoscopy is published in partnership with the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the EAES - European Association for Endoscopic Surgery. See the article: https://lnkd.in/gxvJR_-d See the press release: https://lnkd.in/gMv6__PA #GERD #UnstoppableRefluxStop
-
-
What does Dr. Gopal Grandhige, Surgeon and Founder of the Tampa Reflux Institute, enjoy about the American Foregut Society Annual Meeting? It's a great way to stay on top of innovation! We couldn't agree more, as the latest innovation in anti-refulx surgery, we're excited to answer all your questions about the RefluxStop® procedure to treat chronic GERD. In the meantime take a look at this article about patient outcomes 3 years after the RefluxStop® procedure: https://lnkd.in/gjqFANsZ #AFS2024 #AFSAnnualMeeting
-
RefluxStop™ hat dies direkt geteilt
È così emozionante vedere questa intervista con il dottor Adolfo Renzi su Televomero, guarda la registrazione: https://lnkd.in/ggake8G3 So exciting to see this interview with Dr. Adolfo Renzi on Italy's Televomero, check out the recording: https://lnkd.in/ggake8G3
-